Cargando…
ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
OBJECTIVE: Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Although the contradictory role of ADORA1 has been explored in certain types of cancers, its clinical significance and function in hepatocellular carcinoma cells are largely unknown. MATERIALS AND METHODS: The level of ADORA...
Autores principales: | Ni, Sheng, Wei, Qian, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719345/ https://www.ncbi.nlm.nih.gov/pubmed/33293832 http://dx.doi.org/10.2147/OTT.S272621 |
Ejemplares similares
-
ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma
por: Ran, Longyan, et al.
Publicado: (2023) -
Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022) -
Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022) -
ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis
por: Pu, Jian, et al.
Publicado: (2021) -
TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)